Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis (vol 12, pg 1457, 2023)

被引：0
|
作者：
Clavelou, Pierre [1 ,2 ]
Castelnovo, Giovanni [2 ]
Pourcher, Valerie [3 ]
De Seze, Jerome [4 ]
Vermersch, Patrick [5 ]
Ben-Amor, Ali-Frederic [6 ]
Savarin, Carine [7 ]
Defer, Gilles [8 ]
机构：
[1] Clermont Ferrand Univ Hosp, Dept Neurol, F-1 Clermont Ferrand, France
[2] Univ Nimes Hosp, Dept Neurol, Hop Caremeau, Nimes, France
[3] Inst Pierre Louis dEpidemiol & Sante Publ Paris, Sorbonne Univ, Pitie Salpetriere Hosp, Dept Infect & Trop Dis, Paris, France
[4] Strasbourg Univ Hosp, Dept Neurol, Strasbourg, France
[5] Univ Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France
[6] Global Med Affairs Neurol & Immunol, Ares Trading SA affiliate Merck KGaA, Darmstadt, Switzerland
[7] Dept Neurol, Med Affairs affiliate Merck KGaA, Darmstadt, France
[8] Caen Univ Hosp, Dept Neurol, Caen, France
来源：
NEUROLOGY AND THERAPY | 2024年 / 13卷 / 01期
关键词：
D O I：
10.1007/s40120-023-00564-8
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：255 / 256
页数：2
相关论文
共 50 条
  • [21] Long-term management of multiple sclerosis patients treated with cladribine tablets: an expert opinion
    Meuth, Sven G.
    Bayas, Antonios
    Kallmann, Boris
    Kleinschnitz, Christoph
    Linker, Ralf
    Rieckmann, Peter
    Maeurer, Mathias
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (16) : 1965 - 1969
  • [22] Narrative Review on the Use of Cladribine Tablets as Exit Therapy for Stable Elderly Patients with Multiple Sclerosis
    de Seze, Jerome
    Dive, Dominique
    Ayrignac, Xavier
    Castelnovo, Giovanni
    Payet, Marianne
    Rayah, Amel
    Gobbi, Claudio
    Vermersch, Patrick
    Zecca, Chiara
    NEUROLOGY AND THERAPY, 2024, 13 (03) : 519 - 533
  • [23] A real-world single-centre analysis of the safety and efficacy of cladribine tablets for relapsing multiple sclerosis
    Aerts, S.
    Khan, H.
    Severijns, D.
    Popescu, V.
    Peeters, L. M.
    Van Wijmeersch, B.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 892 - 892
  • [24] Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4
    Centonze, Diego
    Amato, Maria Pia
    Brescia Morra, Vincenzo
    Cocco, Eleonora
    De Stefano, Nicola
    Gasperini, Claudio
    Gallo, Paolo
    Pozzilli, Carlo
    Trojano, Maria
    Filippi, Massimo
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2023, 16
  • [25] Multiple sclerosis patients treated with cladribine tablets: expert opinion on practical management after year 4
    Centonze, Diego
    Amato, Maria Pia
    Morra, Vincenzo Brescia
    Cocco, Eleonora
    De Stefano, Nicola
    Gasperini, Claudio
    Gallo, Paolo
    Pozzilli, Carlo
    Trojano, Maria
    Filippi, Massimo
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2023, 16
  • [26] Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study
    Inshasi, Jihad
    Farouk, Samar
    Shatila, Ahmed
    Hassan, Ali
    Szolics, Miklos
    Thakre, Mona
    Kayed, Deeb
    Krieger, Derk
    Almadani, Abubaker
    Alsaadi, Taoufik
    Benedetti, Beatrice
    Mifsud, Victoria
    Jacob, Anu
    Sayegh, Shatha
    Boshra, Amir
    Alroughani, Raed
    NEUROLOGY AND THERAPY, 2023, 12 (04) : 1309 - 1318
  • [27] Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study
    Jihad Inshasi
    Samar Farouk
    Ahmed Shatila
    Ali Hassan
    Miklos Szolics
    Mona Thakre
    Deeb Kayed
    Derk Krieger
    Abubaker Almadani
    Taoufik Alsaadi
    Beatrice Benedetti
    Victoria Mifsud
    Anu Jacob
    Shatha Sayegh
    Amir Boshra
    Raed Alroughani
    Neurology and Therapy, 2023, 12 : 1309 - 1318
  • [28] Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis (vol 12, pg 1, 2021)
    Zrzavy, Tobias
    Daniels, Esther
    Stuka, Niklas
    Weber, Dennis
    Winkelmann, Alexander
    Rauschka, Helmut
    Hecker, Michael
    Aboulenein-Djamshidian, Fahmy
    Meister, Stefanie
    Leutmezer, Fritz
    Berger, Thomas
    Bsteh, Gabriel
    Zettl, Uwe Klaus
    Rommer, Paulus
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2021, 12
  • [29] Characteristics of relapsing multiple sclerosis patients treated with cladribine tablets in five european countries: multi-year chart review
    Zeng, F.
    Harty, G.
    Wong, S.
    Maslova, E.
    Schade, R.
    Row, B.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 521 - 521
  • [30] Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
    Giovannoni, Gavin
    Sorensen, Per Soelberg
    Cook, Stuart
    Rammohan, Kottil
    Rieckmann, Peter
    Comi, Giancarlo
    Dangond, Fernando
    Adeniji, Abidemi K.
    Vermersch, Patrick
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (12) : 1594 - 1604
12345